Alx Oncology Holdings (ALXO) Total Debt (2019 - 2026)

Alx Oncology Holdings has reported Total Debt for 8 years, with the latest figure at $8.5 million in Q1 2026.

• Quarterly Total Debt fell 14.63% year-over-year to $8.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.5 million (down 14.63% YoY) and the FY2025 annual result came in at $9.7 million, down 1.57% from the prior year.
• Total Debt retreated to $8.5 million in Q1 2026 per ALXO's latest filing, from $9.7 million in the prior quarter.
• Over five years, Total Debt peaked at $11.0 million in Q4 2022 and troughed at $2.5 million in Q2 2022.
• A 5-year average of $8.9 million and a median of $9.8 million in 2024 frame the typical range for Total Debt.
• The sharpest annual moves came in 2022 and 2026: Total Debt surged 577.24% in 2022, then slipped 14.63% in 2026.
• Over 5 years, Total Debt stood at $11.0 million in 2022, then declined by 12.68% to $9.6 million in 2023, then grew by 2.75% to $9.9 million in 2024, then retreated by 1.57% to $9.7 million in 2025, then fell by 12.69% to $8.5 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $8.5 million, $9.7 million, and $10.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.